Return to Search
EN
FAPI PET/CT imaging is a medical imaging technique utilized for the detection of cancer cells and the assessment of cancer spread. FAPI (Fibroblast Activation Protein Inhibitor) is a molecule that specifically targets fibroblast cells. These cells are frequently found in the tumor microenvironment and play a significant role in cancer growth and dissemination. For imaging, Ga-68, a radioactive isotope, is conjugated to the FAPI molecule.
The FAPI PET/CT imaging process involves the following steps:
1. Administration: The patient receives a solution containing the Ga-68-labeled FAPI molecule, typically administered intravenously.
2. Uptake: The FAPI molecule binds to fibroblast cells throughout the body, with a notable concentration around cancer cells.
3. Scanning: The patient is then positioned in a PET/CT scanner. This device combines PET (Positron Emission Tomography) and CT (Computed Tomography) techniques to acquire three-dimensional images of cancer cells and fibroblast cells.
4. Analysis: The resulting images display both radioactive signals from FAPI uptake and detailed anatomical structures. This enables physicians to accurately assess the cancer's location, extent of spread, and response to therapeutic interventions.
FAPI PET/CT imaging is a valuable tool in oncology, facilitating the differentiation between benign and malignant lesions, the detection of metastases, and the optimization of treatment strategies. It is important to note that the availability and suitability of this method may vary across hospitals and individual cases, and its application should always be determined by a qualified physician.
What is FAPI PET/CT Imaging?
The FAPI PET/CT imaging process involves the following steps:
1. Administration: The patient receives a solution containing the Ga-68-labeled FAPI molecule, typically administered intravenously.
2. Uptake: The FAPI molecule binds to fibroblast cells throughout the body, with a notable concentration around cancer cells.
3. Scanning: The patient is then positioned in a PET/CT scanner. This device combines PET (Positron Emission Tomography) and CT (Computed Tomography) techniques to acquire three-dimensional images of cancer cells and fibroblast cells.
4. Analysis: The resulting images display both radioactive signals from FAPI uptake and detailed anatomical structures. This enables physicians to accurately assess the cancer's location, extent of spread, and response to therapeutic interventions.
FAPI PET/CT imaging is a valuable tool in oncology, facilitating the differentiation between benign and malignant lesions, the detection of metastases, and the optimization of treatment strategies. It is important to note that the availability and suitability of this method may vary across hospitals and individual cases, and its application should always be determined by a qualified physician.